Rat RT6 proteins, and perhaps mouse Rt6, identify a set of immunoregul
atory T lymphocytes. Rat RT6.1 (RT6.1) and rat RT6.2 (RT6.2) are NAD g
lycohydrolases, which catalyze auto-ADP-ribosylation, but not ADP-ribo
sylation of exogenous proteins. Mouse Rt6.1 (mRt6.1) also catalyzes au
to-ADP-ribosylation. The activity of mouse cytotoxic T lymphocytes is
reportedly inhibited by ADP-ribosylation of surface proteins, raising
the possibility that mRt6 may participate in this process. The reactio
ns catalyzed by mRt6, would, however, need to be more diverse than tho
se of the rat homologues and include the ADP-ribosylation of accepters
other than itself. To test this hypothesis, mRt6.1 and rat RT6.2 were
synthesized in Sf9 insect cells and rat mammary adenocarcinoma (NMU)
cells. mRt6.1, but not rat RT6.2, catalyzed the ADP-ribosylation of gu
anidino-containing compounds (e.g. agmatine). Unlike RT6.2, mRt6.1 was
a weak NAD glycohydrolase. In the presence of agmatine, however, the
ratio of [adenine-C-14]ADP-ribosylagmatine formation from [adenine-C-1
4]NAD to [carbonyl-C-14]nicotinamide formation from [carbonyl-C-14]NAD
was similar to 1.0, demonstrating that mRtG.1 is primarily a transfer
ase. ADP-ribosylarginine hydrolase, which preferentially hydrolyzes th
e alpha-anomer of ADP-ribosylarginine, released [U-C-14]arginine from
ADP-ribosyl[U-C-14] arginine synthesized by mRT6.1, consistent with th
e conclusion that mRt6.1 catalyzes a stereospecific S(n)2-like reactio
n. Thus, mRt6.1 is an NAD:arginine ADP-ribosyltransferase capable of c
atalyzing a multiple turnover, stereospecific S(n)2-like reaction.